Testing effectiveness (Phase 2)Looking for participantsNCT06543069
What this trial is testing
Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Who this might be right for
Malignant Peritoneal Mesothelioma, Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 28